I

Inter Pharma PCL
SET:IP

Watchlist Manager
Inter Pharma PCL
SET:IP
Watchlist
Price: 3.6 THB -1.1% Market Closed
Market Cap: 2.2B THB
Have any thoughts about
Inter Pharma PCL?
Write Note

Intrinsic Value

The intrinsic value of one IP stock under the Base Case scenario is 7.83 THB. Compared to the current market price of 3.6 THB, Inter Pharma PCL is Undervalued by 54%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IP Intrinsic Value
7.83 THB
Undervaluation 54%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation Backtest
Inter Pharma PCL

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for IP cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about IP?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Inter Pharma PCL

Provide an overview of the primary business activities
of Inter Pharma PCL.

What unique competitive advantages
does Inter Pharma PCL hold over its rivals?

What risks and challenges
does Inter Pharma PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Inter Pharma PCL.

Provide P/S
for Inter Pharma PCL.

Provide P/E
for Inter Pharma PCL.

Provide P/OCF
for Inter Pharma PCL.

Provide P/FCFE
for Inter Pharma PCL.

Provide P/B
for Inter Pharma PCL.

Provide EV/S
for Inter Pharma PCL.

Provide EV/GP
for Inter Pharma PCL.

Provide EV/EBITDA
for Inter Pharma PCL.

Provide EV/EBIT
for Inter Pharma PCL.

Provide EV/OCF
for Inter Pharma PCL.

Provide EV/FCFF
for Inter Pharma PCL.

Provide EV/IC
for Inter Pharma PCL.

Show me price targets
for Inter Pharma PCL made by professional analysts.

What are the Revenue projections
for Inter Pharma PCL?

How accurate were the past Revenue estimates
for Inter Pharma PCL?

What are the Net Income projections
for Inter Pharma PCL?

How accurate were the past Net Income estimates
for Inter Pharma PCL?

What are the EPS projections
for Inter Pharma PCL?

How accurate were the past EPS estimates
for Inter Pharma PCL?

What are the EBIT projections
for Inter Pharma PCL?

How accurate were the past EBIT estimates
for Inter Pharma PCL?

Compare the revenue forecasts
for Inter Pharma PCL with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Inter Pharma PCL and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Inter Pharma PCL against its competitors.

Analyze the profit margins
(gross, operating, and net) of Inter Pharma PCL compared to its peers.

Compare the P/E ratios
of Inter Pharma PCL against its peers.

Discuss the investment returns and shareholder value creation
comparing Inter Pharma PCL with its peers.

Analyze the financial leverage
of Inter Pharma PCL compared to its main competitors.

Show all profitability ratios
for Inter Pharma PCL.

Provide ROE
for Inter Pharma PCL.

Provide ROA
for Inter Pharma PCL.

Provide ROIC
for Inter Pharma PCL.

Provide ROCE
for Inter Pharma PCL.

Provide Gross Margin
for Inter Pharma PCL.

Provide Operating Margin
for Inter Pharma PCL.

Provide Net Margin
for Inter Pharma PCL.

Provide FCF Margin
for Inter Pharma PCL.

Show all solvency ratios
for Inter Pharma PCL.

Provide D/E Ratio
for Inter Pharma PCL.

Provide D/A Ratio
for Inter Pharma PCL.

Provide Interest Coverage Ratio
for Inter Pharma PCL.

Provide Altman Z-Score Ratio
for Inter Pharma PCL.

Provide Quick Ratio
for Inter Pharma PCL.

Provide Current Ratio
for Inter Pharma PCL.

Provide Cash Ratio
for Inter Pharma PCL.

What is the historical Revenue growth
over the last 5 years for Inter Pharma PCL?

What is the historical Net Income growth
over the last 5 years for Inter Pharma PCL?

What is the current Free Cash Flow
of Inter Pharma PCL?

Discuss the annual earnings per share (EPS)
trend over the past five years for Inter Pharma PCL.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Inter Pharma PCL

Current Assets 1.2B
Cash & Short-Term Investments 384.2m
Receivables 427.9m
Other Current Assets 357.6m
Non-Current Assets 1.8B
Long-Term Investments 43.7m
PP&E 946.9m
Intangibles 687.1m
Other Non-Current Assets 114.4m
Current Liabilities 480.8m
Accounts Payable 199.2m
Accrued Liabilities 40.1m
Short-Term Debt 46.1m
Other Current Liabilities 195.4m
Non-Current Liabilities 552.1m
Long-Term Debt 249.8m
Other Non-Current Liabilities 302.3m
Efficiency

Earnings Waterfall
Inter Pharma PCL

Revenue
1.8B THB
Cost of Revenue
-1.1B THB
Gross Profit
653m THB
Operating Expenses
-581.8m THB
Operating Income
71.2m THB
Other Expenses
-44.7m THB
Net Income
26.5m THB

Free Cash Flow Analysis
Inter Pharma PCL

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

IP Profitability Score
Profitability Due Diligence

Inter Pharma PCL's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Operating Income
Positive 3-Year Average ROIC
49/100
Profitability
Score

Inter Pharma PCL's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

IP Solvency Score
Solvency Due Diligence

Inter Pharma PCL's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
57/100
Solvency
Score

Inter Pharma PCL's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IP Price Targets Summary
Inter Pharma PCL

There are no price targets for IP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IP?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for IP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Inter Pharma PCL

Country

Thailand

Industry

Consumer products

Market Cap

2.2B THB

Dividend Yield

0.97%

Description

Inter Pharma PCL is engaged in biopharmaceutical business. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2019-11-05. The firm is principally engaged in the importing, manufacturing and distribution of dietary supplement product for humans and animals. The firm provides wellness and anti-aging products, aesthetic innovation products, animal health products and livestock products. Its wellness and anti-aging products include Probac7, Probac10 plus, TS6, Beta Glucan Plus, Pure Krill Oil, Astacurmin and YUUU Cleansing Mousse. Its aesthetic innovation products include Perfectha Complement, Perfectha Derm, Perfectha Deep and Perfectha Subskin. The Company’s animal health products include Dr.Choice Cal-B, Dr.Choice Cardi-B, Petinol, Pet Select Senior, Pet Select Osteoflex and Malaseb Shampoo for dogs and cats. The company also offers pet foods for dogs and cats. Its subsidiaries include Inter Vetta Co., Ltd., Modern Pharma Co., Ltd. and Inter Petrina Co., Ltd.

Contact

BANGKOK METROPOLIS
Bangkok
140/9 ITF Tower 9th Floor, Silom Road, Suriyawong
+6626340225
www.interpharma.co.th

IPO

2019-11-05

Employees

282

Officers

CEO & Director
Dr. Trinnawat Thanitnithiphan
Acting CFO & Acting Director of Accounting
Ms. Chatkaew Krudkosol
Director of Operations & Director
Ms. Napaporn Dechakarat
Human Resources Director & Director
Ms. Apimon Posri
Company Secretary
Ms. Chompunuch Meevang

See Also

Discover More
What is the Intrinsic Value of one IP stock?

The intrinsic value of one IP stock under the Base Case scenario is 7.83 THB.

Is IP stock undervalued or overvalued?

Compared to the current market price of 3.6 THB, Inter Pharma PCL is Undervalued by 54%.

Back to Top